M
Milica G. Kramberger
Researcher at Ljubljana University Medical Centre
Publications - 81
Citations - 3117
Milica G. Kramberger is an academic researcher from Ljubljana University Medical Centre. The author has contributed to research in topics: Dementia & Dementia with Lewy bodies. The author has an hindex of 26, co-authored 71 publications receiving 2156 citations. Previous affiliations of Milica G. Kramberger include University of Ljubljana & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.
Katrin Jekel,Marinella Damian,Carina Wattmo,Lucrezia Hausner,Roger Bullock,Peter J. Connelly,Bruno Dubois,Maria Eriksdotter,Michael Ewers,Elmar Graessel,Milica G. Kramberger,Emma Law,Patrizia Mecocci,José Luis Molinuevo,Louise Nygård,Marcel Olde-Rikkert,Jean-Marc Orgogozo,Florence Pasquier,Karine Pérès,Karine Pérès,Eric Salmon,Sietske A.M. Sikkes,Tomasz Sobów,René Spiegel,Magda Tsolaki,Bengt Winblad,Lutz Frölich +26 more
TL;DR: IADL requiring higher neuropsychological functioning seem to be most severely affected in patients with MCI, and the development of performance-based assessment instruments should be intensified, as they allow a valid and reliable assessment of subtle IADL deficits in MCI.
Journal ArticleDOI
EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease
Pablo Martinez-Martin,Prashanth Reddy,Regina Katzenschlager,Angelo Antonini,Antoniya Todorova,Per Odin,Tove Henriksen,Anne Martin,Daniela Calandrella,Alexandra Rizos,Narissah Bryndum,Arne Glad,Haidar S. Dafsari,Lars Timmermann,Georg Ebersbach,Milica G. Kramberger,Michael Samuel,Karoline Wenzel,Volker Tomantschger,Alexander Storch,Heinz Reichmann,Zvezdan Pirtošek,Maja Trošt,Per Svenningsson,Sven Pålhagen,Jens Volkmann,K. Ray Chaudhuri +26 more
TL;DR: It is reported that, in advanced Parkinson's patients, both IJLI and Apo infusion therapy appear to provide a robust improvement in motor symptoms, motor complications, quality‐of‐life, and some NMS.
Journal ArticleDOI
Neuropsychiatric Symptoms in Parkinson's Disease.
TL;DR: A multidisciplinary approach is essential to improve the overall outcome of PD also through raised awareness and enriched knowledge on NPS.
Journal ArticleDOI
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
Willemijn J. Jansen,Rik Ossenkoppele,Betty M. Tijms,Anne M. Fagan,Oskar Hansson,William E. Klunk,Wiesje M. van der Flier,Victor L. Villemagne,Giovanni B. Frisoni,Adam S. Fleisher,Adam S. Fleisher,Alberto Lleó,Mark A. Mintun,Anders Wallin,Sebastiaan Engelborghs,Duk L. Na,Gaël Chételat,José Luis Molinuevo,Susan M. Landau,Niklas Mattsson,Johannes Kornhuber,Osama Sabri,Christopher C. Rowe,Lucilla Parnetti,Julius Popp,Tormod Fladby,William J. Jagust,Pauline Aalten,Dong Young Lee,Rik Vandenberghe,Catarina R. Oliveira,Elisabeth Kapaki,Lutz Froelich,Adrian Ivanoiu,Tomasz Gabryelewicz,Marcel M. Verbeek,Pascual Sánchez-Juan,Helmut Hildebrandt,Vincent Camus,Marzena Zboch,David J. Brooks,Alexander Drzezga,Juha O. Rinne,Andrew B. Newberg,Alexandre de Mendonça,Marie Sarazin,Gil D. Rabinovici,Karine Madsen,Milica G. Kramberger,Agneta Nordberg,Vincent Mok,Barbara Mroczko,David A. Wolk,Philipp T. Meyer,Magda Tsolaki,Philip Scheltens,Frans R.J. Verhey,Pieter Jelle Visser,Pieter Jelle Visser,Dag Aarsland,Daniel Alcolea,Myriam Alexander,Ina S. Almdahl,Steven E. Arnold,Inês Baldeiras,Henryk Barthel,Bart N.M. van Berckel,Kaj Blennow,Kaj Blennow,Mark A. van Buchem,Enrica Cavedo,Kewei Chen,Elena Chipi,Ann D. Cohen,Stefan Förster,Juan Fortea,Kristian Steen Frederiksen,Yvonne Freund-Levi,Olymbia Gkatzima,Mark Forrest Gordon,Timo Grimmer,Harald Hampel,Harald Hampel,Lucrezia Hausner,Sabine Hellwig,Sanna-Kaisa Herukka,Peter Johannsen,Aleksandra Klimkowicz-Mrowiec,Sebastian Köhler,Norman Koglin,Koen Van Laere,Mony J. de Leon,Viviana Lisetti,Wolfgang Maier,Jan Marcusson,Olga Meulenbroek,Hanne M. Møllergård,John C. Morris,Arto Nordlund,Gerald Novak,George P. Paraskevas,Gayan Perera,Gayan Perera,Oliver Peters,Inez H.G.B. Ramakers,Lorena Rami,Eloy Rodríguez-Rodríguez,Catherine M. Roe,Uroš Rot,Eckart Rüther,Isabel Santana,Johannes Schröder,Sang W. Seo,Hilkka Soininen,Luiza Spiru,Erik Stomrud,Hanne Struyfs,Charlotte E. Teunissen,Stephanie J.B. Vos,Linda J C van Waalwijk van Doorn,Gunhild Waldemar,Åsa K. Wallin,Jens Wiltfang,Henrik Zetterberg,Henrik Zetterberg,Henrik Zetterberg +125 more
TL;DR: Low cognitive scores had limited utility for screening of amyloid positivity in persons with normal cognition and those with MCI and their value as a screening measure for early AD among persons without dementia is limited.
Journal ArticleDOI
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia
Anja Hviid Simonsen,Sanna-Kaisa Herukka,Niels Andreasen,Inês Baldeiras,Maria Bjerke,Kaj Blennow,Sebastiaan Engelborghs,Giovanni B. Frisoni,Tomasz Gabryelewicz,Samantha Galluzzi,Ron Handels,Milica G. Kramberger,Agnieszka Kulczyńska,José Luis Molinuevo,Barbara Mroczko,Agneta Nordberg,Catarina R. Oliveira,Markus Otto,Juha O. Rinne,Uroš Rot,Esen Saka,Hilkka Soininen,Hanne Struyfs,Silvia Suardi,Pieter Jelle Visser,Pieter Jelle Visser,Bengt Winblad,Henrik Zetterberg,Henrik Zetterberg,Gunhild Waldemar +29 more
TL;DR: There is sufficient evidence to support a recommendation to use CSF AD biomarkers as a supplement to clinical evaluation, particularly in uncertain and atypical cases, to identify or exclude AD as the cause of dementia.